<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 23-year-old male suffering from severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) weighing 60 kg was successfully treated by unrelated allo-CBSCT (cord blood stem cell transplantation) </plain></SENT>
<SENT sid="1" pm="."><plain>A six-loci HLA-identical umbilical cord blood (UCB) was infused after conditioning with low-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (<z:chebi fb="3" ids="3498">CTX</z:chebi>) and antilymphocyte globulin (ALG) </plain></SENT>
<SENT sid="2" pm="."><plain>The prophylaxis of GVHD consisted of CsA and MTX </plain></SENT>
<SENT sid="3" pm="."><plain>The infused cord blood provided 1.89 x 10(7) nucleated cells per kg, CD34-positive cells: 0.89% </plain></SENT>
<SENT sid="4" pm="."><plain>Neutrophils &gt;0.5 x 10(9)/l were reached 10 days after transplant, and platelets greater than 50.0 x 10(9)/l at day 26 </plain></SENT>
<SENT sid="5" pm="."><plain>RBC and platelet transfusion independence were reached on days 15 and 18 </plain></SENT>
<SENT sid="6" pm="."><plain>The patient developed grade 1 skin GVHD 10 months after engraftment of the donor cells </plain></SENT>
<SENT sid="7" pm="."><plain>Microsatellite DNA fingerprinting indicated a stable and persistent donor-recipient mixed chimerism, whilst the circulating red cells remain of host origin </plain></SENT>
</text></document>